Literature DB >> 29271489

Differential mechanisms of adenosine- and ATPγS-induced microvascular endothelial barrier strengthening.

Róbert Bátori1, Sanjiv Kumar1, Zsuzsanna Bordán1, Mary Cherian-Shaw1, Anita Kovács-Kása1, Justin A MacDonald2, David J R Fulton1,3, Ferenc Erdődi4,5, Alexander D Verin1,6.   

Abstract

Maintenance of the endothelial cell (EC) barrier is critical to vascular homeostasis and a loss of barrier integrity results in increased vascular permeability. While the mechanisms that govern increased EC permeability have been under intense investigation over the past several decades, the processes regulating the preservation/restoration of the EC barrier remain poorly understood. Herein we show that the extracellular purines, adenosine (Ado) and adenosine 5'-[γ-thio]-triphosphate (ATPγS) can strengthen the barrier function of human lung microvascular EC (HLMVEC). This ability involves protein kinase A (PKA) activation and decreases in myosin light chain 20 (MLC20) phosphorylation secondary to the involvement of MLC phosphatase (MLCP). In contrast to Ado, ATPγS-induced PKA activation is accompanied by a modest, but significant decrease in cyclic adenosine monophosphate (cAMP) levels supporting the existence of an unconventional cAMP-independent pathway of PKA activation. Furthermore, ATPγS-induced EC barrier strengthening does not involve the Rap guanine nucleotide exchange factor 3 (EPAC1) which is directly activated by cAMP but is instead dependent upon PKA-anchor protein 2 (AKAP2) expression. We also found that AKAP2 can directly interact with the myosin phosphatase-targeting protein MYPT1 and that depletion of AKAP2 abolished ATPγS-induced increases in transendothelial electrical resistance. Ado-induced strengthening of the HLMVEC barrier required the coordinated activation of PKA and EPAC1 in a cAMP-dependent manner. In summary, ATPγS-induced enhancement of the EC barrier is EPAC1-independent and is instead mediated by activation of PKA which is then guided by AKAP2, in a cAMP-independent mechanism, to activate MLCP which dephosphorylates MLC20 resulting in reduced EC contraction and preservation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATPγS; PKA; adenosine; endothelial barrier protection; myosin light chain

Mesh:

Substances:

Year:  2018        PMID: 29271489      PMCID: PMC7273968          DOI: 10.1002/jcp.26419

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  66 in total

1.  ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway.

Authors:  Paola Scodelaro Bilbao; Graciela Santillán; Ricardo Boland
Journal:  Arch Biochem Biophys       Date:  2010-05-05       Impact factor: 4.013

Review 2.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

Review 3.  Signaling mechanisms regulating endothelial permeability.

Authors:  Dolly Mehta; Asrar B Malik
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

4.  Molecular cloning and characterization of rat P2Y4 nucleotide receptor.

Authors:  Y D Bogdanov; S S Wildman; M P Clements; B F King; G Burnstock
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

5.  Rac1 regulates myosin II phosphorylation through regulation of myosin light chain phosphatase.

Authors:  Keita Shibata; Hiroyasu Sakai; Qian Huang; Hirotoshi Kamata; Yoshihiko Chiba; Miwa Misawa; Reiko Ikebe; Mitsuo Ikebe
Journal:  J Cell Physiol       Date:  2015-06       Impact factor: 6.384

6.  Endothelial Basement Membrane Laminin 511 Contributes to Endothelial Junctional Tightness and Thereby Inhibits Leukocyte Transmigration.

Authors:  Jian Song; Xueli Zhang; Konrad Buscher; Ying Wang; Huiyu Wang; Jacopo Di Russo; Lixia Li; Stefan Lütke-Enking; Alexander Zarbock; Anika Stadtmann; Paul Striewski; Benedikt Wirth; Ivan Kuzmanov; Heinz Wiendl; Dörte Schulte; Dietmar Vestweber; Lydia Sorokin
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

7.  Multiple interactions within the AKAP220 signaling complex contribute to protein phosphatase 1 regulation.

Authors:  R V Schillace; J W Voltz; A T Sim; S Shenolikar; J D Scott
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

8.  Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation.

Authors:  J Niu; R Vaiskunaite; N Suzuki; T Kozasa; D W Carr; N Dulin; T A Voyno-Yasenetskaya
Journal:  Curr Biol       Date:  2001-10-30       Impact factor: 10.834

9.  Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Authors:  Alexander Khromov; Nandini Choudhury; Andra S Stevenson; Avril V Somlyo; Masumi Eto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

10.  P2 receptors in cardiovascular regulation and disease.

Authors:  David Erlinge; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2007-09-21       Impact factor: 3.765

View more
  6 in total

1.  Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.

Authors:  Alexander D Verin; Robert Batori; Anita Kovacs-Kasa; Mary Cherian-Shaw; Sanjiv Kumar; Istvan Czikora; Vijaya Karoor; Derek Strassheim; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

2.  A venous-specific purinergic signaling cascade initiated by Pannexin 1 regulates TNFα-induced increases in endothelial permeability.

Authors:  Daniela Maier-Begandt; Heather Skye Comstra; Samuel A Molina; Nenja Krüger; Claire A Ruddiman; Yen-Lin Chen; Xiaobin Chen; Lauren A Biwer; Scott R Johnstone; Alexander W Lohman; Miranda E Good; Leon J DeLalio; Kwangseok Hong; Hannah M Bacon; Zhen Yan; Swapnil K Sonkusare; Michael Koval; Brant E Isakson
Journal:  Sci Signal       Date:  2021-03-02       Impact factor: 8.192

Review 3.  Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.

Authors:  Mazen Shihan; Tatyana Novoyatleva; Thilo Lehmeyer; Akylbek Sydykov; Ralph T Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-10-20       Impact factor: 3.390

4.  Complex Transcriptional Profiles of the PPP1R12A Gene in Cells of the Circulatory System as Revealed by In Silico Analysis and Reverse Transcription PCR.

Authors:  Paulo André Saldanha; Israel Olapeju Bolanle; Timothy Martin Palmer; Leonid Leonidovich Nikitenko; Francisco Rivero
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

5.  Adenosine and ATPγS protect against bacterial pneumonia-induced acute lung injury.

Authors:  Christine M Gross; Anita Kovacs-Kasa; Mary Louise Meadows; Mary Cherian-Shaw; David J Fulton; Alexander D Verin
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

Review 6.  P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

Authors:  Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.